Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Graeme Smith who wrote (1548)	7/16/1998 6:29:00 AM
From: Bill Wexler	Respond to of 4634

Vasomax will fail because it is completely ineffective. oral Phentolamine shows no significant improvement over placebo in the treatment of ED. Zonagen has not developed any new drug...phentolamine pills already exist on the market, and there are numerous reputable studies that demonstrate negligible efficacy, even when phentolamine is directly injected into the penis. Pfizer spent half a billion dollars to develop Viagra. Check out the FDA and Pfizer reports on Viagra. Looks like real science, doesn't it? viagra.com Zonagen spent a few bucks and some cheap stock to buy two worthless patents and to repackage 50 year-old generic vasodilator. Note that Zonagen's web site has been down for quite some time... zonagen.com Zonagen started out as a company to develop a non-surgical method for spaying dogs. They then got into the fraud business by trying to copy a compound known as Chitosan and patenting it as their own (Immumax). There is absolutely zero doubt in my mind that Zonagen has perpetrated this fraud for the sole purpose of artificially inflating its stock.